Exploring How Pomalidomide Enhances Immune Response in the Battle Against Multiple Myeloma
Pomalidomide (POM) has emerged as a pivotal agent in the treatment landscape for multiple myeloma, a malignancy that significantly compromises the immune system, rendering patients...











![[Photo 1]](https://bioengineer.org/wp-content/uploads/2025/01/Korea-and-US-Research-Institutes-Boost-Collaborative-Efforts-in-Energy-350x250.jpeg)



